Interactions between hematopoietic progenitor kinase 1 and its adaptor proteins (Review)
- Authors:
- Qing Zhang
- Shu Ding
- Huilin Zhang
-
Affiliations: Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China, Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China, Emergency Department, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China - Published online on: September 13, 2017 https://doi.org/10.3892/mmr.2017.7494
- Pages: 6472-6482
This article is mentioned in:
Abstract
 |
|
Alzabin S, Bhardwaj N, Kiefer F, Sawasdikosol S and Burakoff S: Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation. J Immunol. 182:6187–6194. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou G, Boomer JS and Tan TH: Protein phosphatase 4 is a positive regulator of hematopoietic progenitor kinase 1. J Biol Chem. 279:49551–49561. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Siligardi G, Ruzza P, Hussain R, Cesaro L, Brunati AM, Pinna LA and Donella-Deana A: The SH3 domain of HS1 protein recognizes lysine-rich polyproline motifs. Amino Acids. 42:1361–1370. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sawasdikosol S, Pyarajan S, Alzabin S, Matejovic G and Burakoff SJ: Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway. J Biol Chem. 282:34693–34699. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Liu SK, Smith CA, Arnold R, Kiefer F and McGlade CJ: The adaptor protein Gads (Grb2-related adaptor downstream of Shc) is implicated in coupling hemopoietic progenitor kinase-1 to the activated TCR. J Immunol. 165:1417–1426. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Shui JW, Boomer JS, Han J, Xu J, Dement GA, Zhou G and Tan TH: Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses. Nat Immunol. 8:84–91. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Brenner D, Golks A, Kiefer F, Krammer PH and Arnold R: Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death. EMBO J. 24:4279–4290. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Brenner D, Golks A, Becker M, Müller W, Frey CR, Novak R, Melamed D, Kiefer F, Krammer PH and Arnold R: Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes. Blood. 110:3968–3977. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ling P, Meyer CF, Redmond LP, Shui JW, Davis B, Rich RR, Hu MC, Wange RL and Tan TH: Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling. J Biol Chem. 276:18908–18914. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Arnold R, Patzak IM, Neuhaus B, Vancauwenbergh S, Veillette A, Van Lint J and Kiefer F: Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1. Mol Cell Biol. 25:2364–2383. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Alzabin S, Pyarajan S, Yee H, Kiefer F, Suzuki A, Burakoff S and Sawasdikosol S: Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response. Cancer Immunol Immunother. 59:419–429. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Königsberger S, Peckl-Schmid D, Zaborsky N, Patzak I, Kiefer F and Achatz G: HPK1 associates with SKAP-HOM to negatively regulate Rap1-mediated B-lymphocyte adhesion. PLoS One. 5(pii): e124682010. View Article : Google Scholar : PubMed/NCBI | |
|
Anafi M, Kiefer F, Gish GD, Mbamalu G, Iscove NN and Pawson T: SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1. J Biol Chem. 272:27804–27811. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Ling P, Yao Z, Meyer CF, Wang XS, Oehrl W, Feller SM and Tan TH: Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase. Mol Cell Biol. 19:1359–1368. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Sawasdikosol S, Russo KM and Burakoff SJ: Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcription. Blood. 101:3687–3689. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou G, Lee SC, Yao Z and Tan TH: Hematopoietic progenitor kinase 1 is a component of transforming growth factor beta-induced c-Jun N-terminal kinase signaling cascade. J Biol Chem. 274:13133–13138. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Zhou G, Hu MC, Yao Z and Tan TH: Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction. J Biol Chem. 272:22771–22775. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Nagata Y, Kiefer F, Watanabe T and Todokoro K: Activation of hematopoietic progenitor kinase-1 by erythropoietin. Blood. 93:3347–3354. 1999.PubMed/NCBI | |
|
Arnold R, Frey CR, Müller W, Brenner D, Krammer PH and Kiefer F: Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation. Cell Death Differ. 14:568–575. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chen YR and Tan TH: Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene. 17:173–178. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Balakireva M, Rossé C, Langevin J, Chien YC, Gho M, Gonzy-Treboul G, Voegeling-Lemaire S, Aresta S, Lepesant JA, Bellaiche Y, et al: The Ral/exocyst effector complex counters c-Jun N-terminal kinase-dependent apoptosis in Drosophila melanogaster. Mol Cell Biol. 26:8953–8963. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Ito Y, Pandey P, Sathyanarayana P, Ling P, Rana A, Weichselbaum R, Tan TH, Kufe D and Kharbanda S: Interaction of hematopoietic progenitor kinase 1 and c-Abl tyrosine kinase in response to genotoxic stress. J Biol Chem. 276:18130–18138. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Hu MC, Wang Yp, Qiu WR, Mikhail A, Meyer CF and Tan TH: Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IkappaB kinases (IKK-alpha/beta) and IKK-beta is a developmentally regulated protein kinase. Oncogene. 18:5514–5524. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Chen YR, Meyer CF, Ahmed B, Yao Z and Tan TH: Caspase-mediated cleavage and functional changes of hematopoietic progenitor kinase 1 (HPK1). Oncogene. 18:7370–7377. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Arnold R, Liou J, Drexler HC, Weiss A and Kiefer F: Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB. J Biol Chem. 276:14675–14684. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Schulze-Luehrmann J, Santner-Nanan B, Jha MK, Schimpl A, Avots A and Serfling E: Hematopoietic progenitor kinase 1 supports apoptosis of T lymphocytes. Blood. 100:954–960. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Chen YR and Tan TH: The c-Jun N-terminal kinase pathway and apoptotic signaling (Review). Int J Oncol. 16:651–662. 2000.PubMed/NCBI | |
|
Brenner D, Krammer PH and Arnold R: Concepts of activated T cell death. Crit Rev Oncol Hematol. 66:52–64. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Krammer PH, Arnold R and Lavrik IN: Life and death in peripheral T cells. Nat Rev Immunol. 7:532–542. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Song X, Logsdon C, Zhou G, Evans DB, Abbruzzese JL, Hamilton SR, Tan TH and Wang H: Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. Cancer Res. 69:1063–1070. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Long H, Liao J, Zhao M, Liang G, Wu X, Zhang P, Ding S, Luo S and Lu Q: Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus. J Autoimmun. 37:180–189. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Li JP, Kuo HK, Chiu LL, Dement GA, Lan JL, Chen DY, Yang CY, Hu H and Tan TH: Down-regulation of B cell receptor signaling by hematopoietic progenitor kinase 1 (HPK1)-mediated phosphorylation and ubiquitination of activated B cell linker protein (BLNK). J Biol Chem. 287:11037–11048. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Stoeckman AK, Baechler EC, Ortmann WA, Behrens TW, Michet CJ and Peterson EJ: A distinct inflammatory gene expression profile in patients with psoriatic arthritis. Genes Immun. 7:583–591. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Batliwalla FM, Li W, Ritchlin CT, Xiao X, Brenner M, Laragione T, Shao T, Durham R, Kemshetti S, Schwarz E, et al: Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol Med. 11:21–29. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Chen-Deutsch X, Kutner A, Harrison JS and Studzinski GP: The pan-caspase inhibitor Q-VD-OPh has anti-leukemia effects and can interact with vitamin D analogs to increase HPK1 signaling in AML cells. Leuk Res. 36:884–888. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chen-Deutsch X and Studzinski GP: Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance. Cell Cycle. 11:1364–1373. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Luo H, Li Y, Chen T, Wu S and Yang L: hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas. Mol Med Rep. 5:260–265. 2012.PubMed/NCBI | |
|
Qian Y, Takeuchi S, Dugu L, Tsuji G, Xie L, Nakahara T, Takahara M, Moroi Y, Tu YT and Furue M: Hematopoietic progenitor kinase 1, mitogen-activated protein/extracellular signal-related protein kinase kinase kinase 1 and phosphomitogen-activated protein kinase kinase 4 are overexpressed in extramammary Paget disease. Am J Dermatopathol. 33:681–686. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, Tan TH and Colburn NH: Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol. 26:1297–1306. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Sawasdikosol S, Zha R, Yang B and Burakoff S: HPK1 as a novel target for cancer immunotherapy. Immunol Res. 54:262–265. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Jakob SM, Pick R, Brechtefeld D, Nussbaum C, Kiefer F, Sperandio M and Walzog B: Hematopoietic progenitor kinase 1 (HPK1) is required for LFA-1-mediated neutrophil recruitment during the acute inflammatory response. Blood. 121:4184–4194. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Geisberger R, Prlic M, Achatz-Straussberger G, Oberndorfer I, Luger E, Lamers M, Crameri R, Appenzeller U, Wienands J, Breitenbach M, et al: Phage display based cloning of proteins interacting with the cytoplasmic tail of membrane immunoglobulins. Dev Immunol. 9:127–134. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Buday L: Membrane-targeting of signalling molecules by SH2/SH3 domain-containing adaptor proteins. Biochim Biophys Acta. 1422:187–204. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Wilkinson B, Wang H and Rudd CE: Positive and negative adaptors in T-cell signalling. Immunology. 111:368–374. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Ma W, Xia C, Ling P, Qiu M, Luo Y, Tan TH and Liu M: Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes. Oncogene. 20:1703–1714. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Han A, Saijo K, Mecklenbräuker I, Tarakhovsky A and Nussenzweig MC: Bam32 links the B cell receptor to ERK and JNK and mediates B cell proliferation but not survival. Immunity. 19:621–632. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Boomer JS and Tan TH: Functional interactions of HPK1 with adaptor proteins. J Cell Biochem. 95:34–44. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Thome M, Charton JE, Pelzer C and Hailfinger S: Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol. 2:a0030042010. View Article : Google Scholar : PubMed/NCBI | |
|
Brenner D, Brechmann M and Röhling S, Tapernoux M, Mock T, Winter D, Lehmann WD, Kiefer F, Thome M, Krammer PH and Röhling S: Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells. Proc Natl Acad Sci USA. 106:14508–14513. 2009; View Article : Google Scholar : PubMed/NCBI | |
|
Chen YR, Kori R, John B and Tan TH: Caspase-mediated cleavage of actin-binding and SH3-domain-containing proteins cortactin, HS1, and HIP-55 during apoptosis. Biochem Biophys Res Commun. 288:981–989. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Patzak IM, Königsberger S, Suzuki A, Mak TW and Kiefer F: HPK1 competes with ADAP for SLP-76 binding and via Rap1 negatively affects T-cell adhesion. Eur J Immunol. 40:3220–3225. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ruzza P, Siligardi G, Donella-Deana A, Calderan A, Hussain R, Rubini C, Cesaro L, Osler A, Guiotto A, Pinna LA and Borin G: 4-Fluoroproline derivative peptides: Effect on PPII conformation and SH3 affinity. J Pept Sci. 12:462–471. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Le Bras S, Foucault I, Foussat A, Brignone C, Acuto O and Deckert M: Recruitment of the actin-binding protein HIP-55 to the immunological synapse regulates T cell receptor signaling and endocytosis. J Biol Chem. 279:15550–15560. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Han J, Shui JW, Zhang X, Zheng B, Han S and Tan TH: HIP-55 is important for T-cell proliferation, cytokine production, and immune responses. Mol Cell Biol. 25:6869–6878. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Han J, Kori R, Shui JW, Chen YR, Yao Z and Tan TH: The SH3 domain-containing adaptor HIP-55 mediates c-Jun N-terminal kinase activation in T cell receptor signaling. J Biol Chem. 278:52195–52202. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Ensenat D, Yao Z, Wang XS, Kori R, Zhou G, Lee SC and Tan TH: A novel src homology 3 domain-containing adaptor protein, HIP-55, that interacts with hematopoietic progenitor kinase 1. J Biol Chem. 274:33945–33950. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Liou J, Kiefer F, Dang A, Hashimoto A, Cobb MH, Kurosaki T and Weiss A: HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1. Immunity. 12:399–408. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Oehrl W, Kardinal C, Ruf S, Adermann K, Groffen J, Feng GS, Blenis J, Tan TH and Feller SM: The germinal center kinase (GCK)-related protein kinases HPK1 and KHS are candidates for highly selective signal transducers of Crk family adapter proteins. Oncogene. 17:1893–1901. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Lewitzky M, Harkiolaki M, Domart MC, Jones EY and Feller SM: Mona/Gads SH3C binding to hematopoietic progenitor kinase 1 (HPK1) combines an atypical SH3 binding motif, R/KXXK, with a classical PXXP motif embedded in a polyproline type II (PPII) helix. J Biol Chem. 279:28724–28732. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Shen R, Ouyang YB, Qu CK, Alonso A, Sperzel L, Mustelin T, Kaplan MH and Feng GS: Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 induction. Mol Cell Biol. 22:3230–3236. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Lasserre R, Cuche C, Blecher-Gonen R, Libman E, Biquand E, Danckaert A, Yablonski D, Alcover A and Di Bartolo V: Release of serine/threonine-phosphorylated adaptors from signaling microclusters down-regulates T cell activation. J Cell Biol. 195:839–853. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sauer K, Liou J, Singh SB, Yablonski D, Weiss A and Perlmutter RM: Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes. J Biol Chem. 276:45207–45216. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Tsuji S, Okamoto M, Yamada K, Okamoto N, Goitsuka R, Arnold R, Kiefer F and Kitamura D: B cell adaptor containing src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1. J Exp Med. 194:529–539. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Yu J, Riou C, Davidson D, Minhas R, Robson JD, Julius M, Arnold R, Kiefer F and Veillette A: Synergistic regulation of immunoreceptor signaling by SLP-76-related adaptor Clnk and serine/threonine protein kinase HPK-1. Mol Cell Biol. 21:6102–6112. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Burns JC, Corbo E, Degen J, Gohil M, Anterasian C, Schraven B, Koretzky GA, Kliche S and Jordan MS: The SLP-76 Src homology 2 domain is required for T cell development and activation. J Immunol. 187:4459–4466. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Li JP, Chiu LL, Lan JL, Chen DY, Boomer J and Tan TH: Attenuation of T cell receptor signaling by serine phosphorylation-mediated lysine 30 ubiquitination of SLP-76 protein. J Biol Chem. 287:34091–34100. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Di Bartolo V, Montagne B, Salek M, Jungwirth B, Carrette F, Fourtane J, Sol-Foulon N, Michel F, Schwartz O, Lehmann WD and Acuto O: A novel pathway down-modulating T cell activation involves HPK-1-dependent recruitment of 14-3-3 proteins on SLP-76. J Exp Med. 204:681–691. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Utting O, Sedgmen BJ, Watts TH, Shi X, Rottapel R, Iulianella A, Lohnes D and Veillette A: Immune functions in mice lacking Clnk, an SLP-76-related adaptor expressed in a subset of immune cells. Mol Cell Biol. 24:6067–6075. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Girardin SE and Yaniv M: A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation. EMBO J. 20:3437–3446. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kiefer F, Tibbles LA, Anafi M, Janssen A, Zanke BW, Lassam N, Pawson T, Woodgett JR and Iscove NN: HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway. EMBO J. 15:7013–7025. 1996.PubMed/NCBI | |
|
Hu MC, Qiu WR, Wang X, Meyer CF and Tan TH: Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade. Genes Dev. 10:2251–2264. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Marshall AJ, Niiro H, Lerner CG, Yun TJ, Thomas S, Disteche CM and Clark EA: A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase. J Exp Med. 191:1319–1332. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Hehner SP, Hofmann TG, Dienz O, Droge W and Schmitz ML: Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor- and CD28-mediated activation of JNK, p38, and interleukin-2 transcription. J Biol Chem. 275:18160–18171. 2000. View Article : Google Scholar : PubMed/NCBI |
